EskesC. Chapter 10: Replacement. In: Practical Handbook on the 3Rs in the Context of the Directive 2010/63/EU. Gianni Dal Negro and Silvia Sabioni. Cambridge: MA; 2021 (In press).
2.
EskesC. The usefulness of integrated strategy approaches in replacing animal experimentation. Ann Ist Super Sanità, 2019:55; 400–404.
3.
Dal NegroG, EskesC, BelzS, et al.One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective. Regul Toxicol Pharmacol, 2018:99; 33–49.
4.
BrowneP, NoyesPD, CaseyWM, et al.Application of adverse outcome pathways to U.S. EPA's endocrine disruptor screening program. Environ Health Perspect, 2017:125; 096001.
5.
DesprezB, BirkB, BlaauboerB, et al.A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity. Toxicol In Vitro, 2019:59; 44–50.
6.
HesselEVS, StaalYCM, PiersmaAH. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing. Toxicol Appl Pharmacol, 2018:354; 136–152.
7.
ShatkinJA, OngKJ. Alternative testing strategies for nanomaterials: State of the science and considerations for risk analysis. Risk Anal, 2016:36; 1564–1580.
8.
HampshireVA, GilbertSH. Refinement, reduction, and replacement (3R) strategies in preclinical testing of medical devices. Toxicol Pathol, 2019:47; 329–338.
9.
KleinstreuerN, HoffmannS, AlepeeN, et al.Non-Animal Methods to Predict Skin Sensitization (II): An assessment of defined approaches. Crit Rev Toxicol, 2018:23; 1–16.